Photo from fda.gov.ph
MANILA, Philippines—The Food and Drug Administration is warning the public against buying a cancer treatment medicine that may cause health complications due to cracks in the vials.
In an advisory, FDA acting Director General Kenneth Hartigan Go advised patients with cancer of the blood not to buy Bortezomib (Velcade) 3.5 mg Lyophilized Powder for Injection (IV/SC) with batch numbers 102424, 102430, 102501, 102502 and 102648.
These batches had been reported in the United States and Germany to have cracked vials, Go said.
Bortezomib is used to treat multiple myeloma, a cancer of the blood.
Go urged doctors and their patients to inspect all their vials of the product for any damage before use.
Those who had bought the medicine and found cracks may contact the FDA through report@fda.gov.ph or Janssen Pharmaceutica at tel. (632)8248968 or Janssendrugsafety_Phil@its.jnj.com.
“Any suspected adverse reactions experienced from the product should be reported immediately to the FDA by visiting www.fda.gov.ph.,” Go said.
RELATED STORIES